Research programme: Graves' disease therapeutics - Thyritope BiosciencesAlternative Names: Thyroid hormone modulators - Thyritope Biosciences; Thyroid-stimulating antibody inhibitors - Thyritope Biosciences
Latest Information Update: 26 Sep 2014
At a glance
- Originator Thyritope Biosciences
- Mechanism of Action Thyroid-stimulating immunoglobulin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Graves' disease
Most Recent Events
- 22 Sep 2014 Early research in Graves' disease in USA (unspecified route)